Drug Profile
FR 182980
Latest Information Update: 31 Aug 1999
Price :
$50
*
At a glance
- Originator Fujisawa
- Class Antihyperlipidaemics
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 Aug 1999 New profile
- 30 Aug 1999 No-Development-Reported for Hypercholesterolaemia in Japan (Unknown route)